1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Health Discovery Corporation

Health Discovery Corporation

HDVY
Health Discovery CorporationUS flagOther OTC
0.00
USD
- -
- -
41,171.00Market Cap
Health Discovery Corporation
HDVY
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
- -
- -
0.01
- -
- -
Revenue per Share
-0.03
-0.02
-0.02
-0.01
-0.01
-0.03
-0.01
- -
- -
- -
- -
-0.01
- -
- -
0.01
- -
-0.01
Basic EPS, GAAP
-0.03
-0.01
-0.01
-0.01
-0.01
-0.03
-0.01
-0.01
-0.01
- -
- -
- -
- -
- -
0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.03
-0.08
-0.09
0.01
-0.09
-0.11
-0.11
-0.11
-0.11
-0.11
-0.1
- -
- -
-0.01
- -
- -
- -
Book Value per Share
-0.01
-0.01
- -
-0.01
- -
- -
-0.01
-0.01
-0.01
- -
- -
- -
-0.01
-0.01
- -
- -
- -
Tangible Book Value per Share
104
116
133
169
174
216
230
232
235
253
266
272
272
272
295
398
406
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
2
1
1
- -
- -
- -
- -
2
- -
- -
Sales/Revenue/Turnover
-1,386.88
-1,237.79
-4,307.63
-3,324.85
-3,249.01
-1,207.41
-2,534.59
-115.88
-118.84
3.73
-1,795.13
-2,192.79
-1,912.3
-1,737.29
5.2
-174,200
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-3
-3
-3
-2
-2
-7
-3
- -
-1
- -
-1
-2
-1
-1
2
-1
-3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-1,410.28
-1,273.12
-4,660.96
-3,267.04
-3,263.39
-1,777.63
-2,122.63
-27.8
-73.55
17.11
-1,316.25
-4,754.13
-1,944.09
-1,795.65
102.76
-75,900
- -
Profit Margin (%)
- -
- -
1
- -
2
3
- -
1
-1
- -
- -
- -
-1
-1
- -
- -
-1
Working Capital
1
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
3
2
4
2
4
4
1
1
- -
1
1
1
- -
-1
- -
- -
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
6.48
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.68
- -
- -
- -
- -
-373.06
- -
- -
Return on Capital (%)
-187.5
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'21
Jun'21
Sep'21
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
404
404
412
Market Capitalization
16
26
72

Working Capital

FRC

•

in mil. unless spec.
Mar'21
Jun'21
Sep'21
Total Current Assets
1
- -
- -
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-24.15%
-34.15%
-179.79%
Free Cash Flow
-128.96%
-226.09%
-162.6%
Net Income, GAAP
-88.52%
-51.84%
-148.62%
Sales/Revenue/Turnover
426%
645.68%
-99.93%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
2
- -
- -
2
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
0.01
- -
- -
0.01
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
Similar Companies
Kallo Inc. (KALO)
Akerna Corp. (KERNW)
Pro Medicus Limited (PMCUF)
Mental Health Technologies Co.,Ltd. (9218.T)
FRISQ Holding AB (publ) (FRISQ.ST)
EGF Theramed Health Corp. (EVAHF)
Business
Health Discovery Corporation (HDVY) operates as a pattern recognition company that applies advanced mathematical techniques to analyze large datasets and uncover hidden patterns, primarily in molecular diagnostics and across diverse industries including life sciences, precision medicine, consumer technology, telecommunications, finance, banking, retail, e-commerce, industrial manufacturing, automotive and aerospace. Its core intellectual property portfolio encompasses Support Vector Machines (SVM), patented mathematical algorithms for precise classification and recursive feature elimination (RFE) that optimize feature selection to enhance model accuracy; Fractal Genomic Modeling (FGM) technology for mapping genetic pathways in disease diagnosis and prevention; and proprietary biomarkers representing biological indicators or genetic expression signatures of specific disease states. The company also maintains assets from Fractal Genomics, LLC, including FGM software, and through its joint venture SVM Capital, LLC, extends SVM applications to financial markets analysis. Founded in 2001 and headquartered at 2002 Summit Boulevard NE, Suite 300, Atlanta, Georgia 30319, United States, Health Discovery Corporation employs a small team of three and targets scientific discovery, healthcare providers, and data-driven enterprises seeking innovative machine learning solutions. The firm operates principally in the United States within the healthcare services and health information services sectors, with SVM and RFE tools originally developed for life sciences now deployed broadly for custom integration and proven results in operational efficiency. No major recent partnerships, funding rounds, acquisitions, new product launches, or strategic expansions have been publicly reported for Health Discovery Corporation in the last one to two years. The company continues to emphasize its foundational IP assets amid ongoing operations in pattern recognition technologies.